pharma · Atopic Dermatitis · Acne Vulgaris
UAS Pharmaceuticals Pty
Galderma Australia Pty Ltd
Galderma Australia Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Atopic Dermatitis, Acne Vulgaris, Prurigo Nodularis. NovaPharmaNews links 4 clinical program(s), 5 drug profile
Castle Hill, AU HQ
2000 Founded
44 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Castle Hill, AU
- Founded
- 2000
- Employees
- 44
- Programs
- 4
- Drugs
- 7
- Patents
- 0
Nemolizumab
Phase 2 · small molecule · Atopic Dermatitis
Nemolizumab for Atopic Dermatitis is a Phase 2 program (small_molecule) at Galderma Australia Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code RD.06.SPR.118126
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Galderma Australia Pty Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Atopic Dermatitis
- Status
- active
- Trials
- 1